Clinical Trial Update: Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by Nyrada Pty Ltd evaluating cardioprotective strategies to prevent reperfusion injury in patients with acute myocardial infarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: Nyrada Pty Ltd | Conditions: Myocardial Infarction, Reperfusion Injury | Phase 2 | Status: RECRUITING